(Q35594556)

9 August 2017

1 reference

title

Importance of P-glycoprotein for drug disposition in humans (English)

1 reference

9 August 2017

Fromm MF

1

1 reference

9 August 2017

1 November 2003

1 reference

European Journal of Clinical Investigation

9 August 2017

1 reference

9 August 2017

33 Suppl 2

1 reference

9 August 2017

6-9

1 reference

Multidrug resistance in cancer: role of ATP-dependent transporters

9 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.33.S2.4.X

Is the multidrug transporter a flippase?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.33.S2.4.X

Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.33.S2.4.X

Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.33.S2.4.X

Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.33.S2.4.X

Role of transport proteins in drug absorption, distribution and excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.33.S2.4.X

The drug efflux-metabolism alliance: biochemical aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.33.S2.4.X

Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.33.S2.4.X

Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.33.S2.4.X

Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine [seecomments]

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.33.S2.4.X

Increased drug delivery to the brain by P-glycoprotein inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.33.S2.4.X

Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.33.S2.4.X

P-glycoprotein and MRP1 expression and reduced ritonavir and saquinavir accumulation in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.33.S2.4.X

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.33.S2.4.X

Identification of functionally variant MDR1 alleles among European Americans and African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.33.S2.4.X

10.1046/J.1365-2362.33.S2.4.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14641550